PepHaūs
PepHaūs publishes 1 rankable monthly figure and a dose sits near it that the seller never ties to the figure, and this site refuses an inferred tie. This site prints no comparable figure for PepHaūs, and the reading behind that is on this page.
Ellis Brandt built this site’s grading methodology and maintains it. Last re-read September 2026.
The figure this seller publishes
PepHaūs publishes 1 rankable monthly figure for tirzepatide. This site prints no comparable figure for PepHaūs, because a figure that does not say what dose it buys cannot be compared with one that does. What follows is what was read, in the words of the person who read it.
Tirzepatide
A dose appears near this figure and the seller never ties the two together. This site refuses an inferred tie: a dose that merely sits beside a price is not the dose that price is for.
The plan grid prints 6-Month Plan $215/mo, Quarterly Plan $227/mo and Monthly $239/mo with no dose against any of them. The only mg in the window is a clinical-trial figure — In the SURMOUNT-1 trial, adults on 15 mg tirzepatide lost an average of about 20% of body weight over 72 weeks — which describes FDA-approved tirzepatide in a trial, not the dose PepHaus dispenses at $239. The other mg on screen is 0 mg, printed to describe weight-loss gummies. Neither can be paired to this price.
The page says the figure covers medication, consultation, supplies, shipping. Read September 2026 from https://thepephaus.com/tirzepatide.
What the page states, and what it leaves out
Talks about pharmacies and names none. No figure this seller publishes states what it buys, so no price is printed here.
Cancellation
Cancellation terms have not been read for PepHaūs. The pass that opened, timed and recorded cancellation terms covered the 60 sellers whose figure states what it buys, and PepHaūs is not one of them. This site therefore states nothing about how PepHaūs handles cancellation — not that terms are absent, only that we have not read them. It is a gap in this site’s reading, and it is recorded as one rather than scored as a silence.
Dose escalation
This seller does not print the titration steps its patients follow. 54 of the 60 sellers whose figure states what it buys do not either. What the four FDA-approved labels set as the escalation is published on this site with no provider named and no paid link.
Go to PepHaūs
PepHaūs pays this site nothing. The link below is unpaid and carries no tracking of any kind. It goes to the page that carries the figure quoted above.
Visit siteWhere this seller is listed
One board per buying decision. Each is the same table with the columns that decision needs, under its own dated and counted title.
- Semaglutide providers54 listed, September 2026
Readers who have settled on semaglutide and are choosing who to buy it from.
- Tirzepatide providers52 listed, September 2026
Readers who have settled on tirzepatide and are choosing who to buy it from.
- Providers that publish a price before the intake59 listed, September 2026
Readers who will not start an intake without seeing a standing rate and what it covers.
- GLP-1 providers with a published price, compared59 listed, September 2026
Readers whose first question is the number, and who want to see what each figure actually buys before comparing them.
- GLP-1 providers for readers paying cash52 listed, September 2026
Readers who are paying out of pocket and need the medication itself inside the published figure, not just the consult.
- GLP-1 telehealth providers60 listed, September 2026
Readers choosing a prescriber rather than a price — who dispenses, what the plan includes, and how to leave it.